Reposal: Difference between revisions

	WikiDoc Resources for Reposal
Articles
Most recent articles on Reposal Most cited articles on Reposal Review articles on Reposal Articles on Reposal in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Reposal Images of Reposal Photos of Reposal Podcasts & MP3s on Reposal Videos on Reposal
Evidence Based Medicine
Cochrane Collaboration on Reposal Bandolier on Reposal TRIP on Reposal
Clinical Trials
Ongoing Trials on Reposal at Clinical Trials.gov Trial results on Reposal Clinical Trials on Reposal at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Reposal NICE Guidance on Reposal NHS PRODIGY Guidance FDA on Reposal CDC on Reposal
Books
Books on Reposal
News
Reposal in the news Be alerted to news on Reposal News trends on Reposal
Commentary
Blogs on Reposal
Definitions
Definitions of Reposal
Patient Resources / Community
Patient resources on Reposal Discussion groups on Reposal Patient Handouts on Reposal Directions to Hospitals Treating Reposal Risk calculators and risk factors for Reposal
Healthcare Provider Resources
Symptoms of Reposal Causes & Risk Factors for Reposal Diagnostic studies for Reposal Treatment of Reposal
Continuing Medical Education (CME)
CME Programs on Reposal
International
Reposal en Espanol Reposal en Francais
Business
Reposal in the Marketplace Patents on Reposal
Experimental / Informatics
List of terms related to Reposal

Reposal
Clinical data
Synonyms	Reposal, 5-Ethyl-5-(bicyclo(3.2.1)octenyl)barbituric acid
ATC code	N05CA12 (WHO) ;
Identifiers
	IUPAC name 5-(3-bicyclo[3.2.1]oct-3-enyl)-5-ethyl-1,3-diazinane-2,4,6-trione;
CAS Number	3625-25-0;
PubChem CID	19254;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C14H18N2O3
Molar mass	262.304 g/mol

Latest revision as of 14:29, 9 April 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Reposal is a barbiturate derivative invented in the 1960s in Denmark. It has sedative, hypnotic and anticonvulsant properties, and was used primarily for the treatment of insomnia. ^[1] ^[2]

↑ Kessing SV, Tarding F, Thomsen AC. Reposal, A New Hypnotic. (Danish) Ugeskrift for Læger. 1963 Dec 6;125:1735-1741.
↑ Nielsen P, Tarding F. The metabolic fate of 5-(bicyclo-3,2,1,-oct-2-en-2-yl)-5-ethyl barbituric acid, (Reposal). Acta Pharmacologica et Toxicologica (Copenhagen). 1968;26(6):521-30.

@@ Line 1: / Line 1: @@
 {{drugbox |
 | IUPAC_name        = 5-(3-bicyclo[3.2.1]oct-3-enyl)-5-ethyl-1,3-diazinane-2,4,6-trione
-| image             = reposal.png
+| image             = Reposal.png
 | width             = 110
 | CAS_number        = 3625-25-0
@@ Line 26: / Line 26: @@
 | routes_of_administration =
 }}
+              __NOTOC__
+{{SI}}
+{{CMG}}
+==Overview==
 '''Reposal''' is a [[barbiturate]] derivative invented in the 1960s in Denmark. It has [[sedative]], [[hypnotic]] and [[anticonvulsant]] properties, and was used primarily for the treatment of [[insomnia]]. <ref> Kessing SV, Tarding F, Thomsen AC. Reposal, A New Hypnotic. (Danish) [[Ugeskrift for Læger]]. 1963 Dec 6;125:1735-1741. </ref>  <ref> Nielsen P, Tarding F. The metabolic fate of 5-(bicyclo-3,2,1,-oct-2-en-2-yl)-5-ethyl barbituric acid, (Reposal). Acta Pharmacologica et Toxicologica (Copenhagen). 1968;26(6):521-30. </ref>
@@ Line 33: / Line 37: @@
 == References ==
-<references />
+{{reflist|2}}
-{{chem-stub}}
 {{barbiturates}}
@@ Line 41: / Line 45: @@
 [[Category:Barbiturates]]
 [[Category:Sedatives]]
-[[de:Reposal]]
+[[Category:Drug]]